Stockreport

Biomerica Reports First Quarter Fiscal 2025 Financial Results

Biomerica, Inc.  (BMRA) 
NASDAQ:AMEX Investor Relations: biomerica.com/company/investor.asp
PDF Total Revenue Increases 6% Over Same Period Last Year Cost-Saving Measures Now Implemented, Expected to Reduce Annual Expenses by 16% to 23%, Representing [Read more]